Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling

Overview of attention for article published in Cancer Discovery, December 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#16 of 4,154)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 60 news stories from 60 outlets.

Abstract In the era of precision medicine, timely cancer genotyping is necessary to guide treatment and glean valuable…

The arrival of immune checkpoint inhibitors (ICIs) turned the diagnosis of advanced non-small-cell lung cancer (NSCLC) from one…

Minimal residual disease (MRD) has the potential to be a useful prognostic tool in personalizing early lines of treatment for…

Although the predictive utility of minimal residual disease has yet to be fully realized in non–small cell lung cancer, it has…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 56 additional news stories.